momelotinib,danazol
sierra oncology
['momentum', 'momelotinib', 'sierra oncology', 'sierra']
at 2022 meeting will present subset analysis from the momentum trial evaluating safety and efficacy for patients with low platelet counts, demonstrating the use of momelotinib in thrombocytopenic patients. #asco22 #oncoalert #bloodcancer 
Sierra Oncology is on a mission to deliver targeted therapies that treat rare forms of cancer. $SRRA #myelofibrosis #raredisease #bloodcancer